John Craig Thompson - Jul 1, 2025 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
Director
Signature
/s/ Sheldon L. Koenig, by power of attorney
Stock symbol
ESPR
Transactions as of
Jul 1, 2025
Transactions value $
$0
Form type
4
Date filed
7/2/2025, 08:21 AM
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
THOMPSON JOHN CRAIG Director C/O ESPERION THERAPEUTICS, INC., 3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR /s/ Sheldon L. Koenig, by power of attorney 2025-07-02 0001509643

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ESPR Stock Option (right to buy) Award $0 +40K $0.00 40K Jul 1, 2025 Common Stock 40K $1.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The awards vest over a three (3) year period in equal annual installments the first of which will be July 1, 2026.